VKTX
NASDAQStockViking Therapeutics, Inc.
$35.31-0.47 (-1.33%)
52-Week Range
$19.98
$42.09
Key Stats
Market Cap
4.1B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.79
Volume
1.6M
Avg Volume
2.5M
Performance
1M
+23.37%
3M
-4.34%
6M
+47.27%
YTD
+0.14%
1Y
+20.03%
3Y
+236.85%
5Y
+430.19%
Price Chart
ETF Exposure
VKTX is held by 92 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| VONV | Vanguard Russell 1000 Value ETF | 0.01% |
| ENHU | iShares Enhanced Large Cap Core Active ETF | 0.01% |
| ESGV | Vanguard ESG U.S. Stock ETF | 0.01% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.01% |
| IWB | iShares Russell 1000 ETF | 0.01% |
| RECS | Columbia Research Enhanced Core ETF | 0.01% |
| SCHB | Schwab U.S. Broad Market ETF | 0.01% |
| TILT | FlexShares Morningstar U.S. Market Factor Tilt Index Fund | 0.01% |
| IWV | iShares Russell 3000 ETF | 0.01% |
| VONE | Vanguard Russell 1000 ETF | 0.01% |
| VTHR | Vanguard Russell 3000 ETF | 0.01% |
| VTI | Vanguard Total Stock Market ETF | 0.01% |
| GTPE | Goldman Sachs MSCI World Private Equity Return Tracker ETF | 0.00% |
| V3AL.L | Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.00% |
| SPGM | State Street SPDR Portfolio MSCI Global Stock Market ETF | 0.00% |
| VT | Vanguard Total World Stock ETF | 0.00% |
| DFUS | Dimensional - US Equity Market ETF | 0.00% |
| EAOA | iShares ESG Aware 80/20 Aggressive Allocation ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| DCOR | Dimensional - US Core Equity 1 ETF | 0.00% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.00% |
| DFAU | Dimensional - US Core Equity Market ETF | 0.00% |
| EAOK | iShares ESG Aware 30/70 Conservative Allocation ETF | 0.00% |
| EAOM | iShares ESG Aware 40/60 Moderate Allocation ETF | 0.00% |
| EAOR | iShares ESG Aware 60/40 Balanced Allocation ETF | 0.00% |
| GGUS | Goldman Sachs MarketBeta Russell 1000 Growth Equity ETF | 0.00% |
| IRTR | iShares LifePath Retirement ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| IWF | iShares Russell 1000 Growth ETF | 0.00% |
| VONG | Vanguard Russell 1000 Growth ETF | 0.00% |
| LSLT | Pacer Salt Low truBeta US Market ETF | 0.00% |
| SLT | Pacer Salt High truBeta US Market ETF | 0.00% |
| TRPL | Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF | 0.00% |
| VETS | Pacer Military Times Best Employers ETF | 0.00% |
| VIRS | Pacer BioThreat Strategy ETF | 0.00% |
PreviousPage 2 of 2
About VKTX ETF Exposure
Viking Therapeutics, Inc. (VKTX) is held by 92 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 4.1B, VKTX is a widely held institutional stock. The stock currently trades at $35.31. Investors can gain exposure to VKTX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold VKTX, sorted by portfolio weight.